HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock
暂无分享,去创建一个
L. Moldawer | F. Moore | S. Reddy | C. Kalynych | C. Leeuwenburgh | S. Dodani | F. Guirgis | V. Grijalva | Jennifer Bowman | A. E. Jones
[1] L. Moldawer,et al. Exploring the Predictive Ability of Dysfunctional High-Density Lipoprotein for Adverse Outcomes in Emergency Department Patients with Sepsis: A Preliminary Investigation , 2017, Shock.
[2] L. Moldawer,et al. HDL Cholesterol Efflux is Impaired in Older Patients with Early Sepsis: A Subanalysis of a Prospective Pilot Study , 2017, Shock.
[3] F. Veglia,et al. Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction[S] , 2017, Journal of Lipid Research.
[4] L. Moldawer,et al. Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome , 2017, Critical care medicine.
[5] John P. Donnelly,et al. Cholesterol levels and long-term rates of community-acquired sepsis , 2016, Critical Care.
[6] K. Walley,et al. Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor , 2016, PloS one.
[7] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[8] C. Fjell,et al. Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis , 2016, Journal of Innate Immunity.
[9] Chong-Jen Yu,et al. Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission. , 2015, Journal of critical care.
[10] I. Dimopoulou,et al. Adipose tissue lipolysis and circulating lipids in acute and subacute critical illness: effects of shock and treatment. , 2014, Journal of critical care.
[11] M. Reilly,et al. PCSK9 is a critical regulator of the innate immune response and septic shock outcome , 2014, Science Translational Medicine.
[12] G. Norata,et al. HDL in innate and adaptive immunity. , 2014, Cardiovascular research.
[13] R. Hotchkiss,et al. Reactivation of Multiple Viruses in Patients with Sepsis , 2014, PloS one.
[14] C. Bonithon-Kopp,et al. Low Preoperative Cholesterol Level Is a Risk Factor of Sepsis and Poor Clinical Outcome in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass* , 2014, Critical care medicine.
[15] A. Remaley,et al. Scavenger Receptor BI and High-Density Lipoprotein Regulate Thymocyte Apoptosis in Sepsis , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[16] A. Gaggar,et al. L-4F Inhibits Lipopolysaccharide-Mediated Activation of Primary Human Neutrophils , 2014, Inflammation.
[17] R. Hotchkiss,et al. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy , 2013, Nature Reviews Immunology.
[18] A. Gaggar,et al. Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis , 2013, PloS one.
[19] Kyuseok Kim,et al. 4F, apolipoprotein AI mimetic peptide, attenuates acute lung injury and improves survival in endotoxemic rats , 2012, The journal of trauma and acute care surgery.
[20] Z. Varghese,et al. Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export , 2012, Journal of gastroenterology and hepatology.
[21] R. Hotchkiss,et al. Immunosuppression in patients who die of sepsis and multiple organ failure. , 2011, JAMA.
[22] D. Sviridov,et al. Neutrophil Activation Is Attenuated by High-Density Lipoprotein and Apolipoprotein A-I in In Vitro and In Vivo Models of Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[23] Pan‐Chyr Yang,et al. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis* , 2005, Critical care medicine.
[24] Kenneth R Feingold,et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. , 2004, Journal of lipid research.
[25] B. Beutler,et al. How we detect microbes and respond to them: the Toll‐like receptors and their transducers , 2003, Journal of leukocyte biology.
[26] J. Verhoef,et al. Lipoprotein metabolism in patients with severe sepsis , 2003, Critical care medicine.
[27] S. Reddy,et al. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. , 2001, Journal of lipid research.
[28] R. Munford,et al. Plasma Lipoproteins Promote the Release of Bacterial Lipopolysaccharide from the Monocyte Cell Surface* , 1999, The Journal of Biological Chemistry.
[29] P. Vadas,et al. Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL. , 1998, Journal of lipid research.
[30] E. Edelman,et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels , 1997, Nature.
[31] J. Parrillo. Pathogenetic mechanisms of septic shock. , 1993, The New England journal of medicine.
[32] G. Coetzee,et al. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. , 1986, The Journal of biological chemistry.
[33] G. Fonarow,et al. formation of , 2022 .